These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 27338029)

  • 1. Predictors of baseline cancer-related cognitive impairment in cancer patients scheduled for a curative treatment.
    Lycke M; Pottel L; Pottel H; Ketelaars L; Stellamans K; Van Eygen K; Vergauwe P; Werbrouck P; Goethals L; Schofield P; Boterberg T; Debruyne PR
    Psychooncology; 2017 May; 26(5):632-639. PubMed ID: 27338029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The distress thermometer predicts subjective, but not objective, cognitive complaints six months after treatment initiation in cancer patients.
    Lycke M; Lefebvre T; Pottel L; Pottel H; Ketelaars L; Stellamans K; Eygen KV; Vergauwe P; Werbrouck P; Goethals L; Schofield P; Boterberg T; Debruyne PR
    J Psychosoc Oncol; 2017; 35(6):741-757. PubMed ID: 28816636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological profiles of breast cancer and brain tumor cohorts in Northeast Ontario, Canada.
    Mariani M; Collins MWG
    Support Care Cancer; 2018 Nov; 26(11):3801-3809. PubMed ID: 29774475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premorbid adjustment predictors of cognitive dysfunction in schizophrenia.
    Stefanatou P; Karatosidi CS; Tsompanaki E; Kattoulas E; Stefanis NC; Smyrnis N
    Psychiatry Res; 2018 Sep; 267():249-255. PubMed ID: 29940456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study.
    Duivon M; Lequesne J; Di Meglio A; Pradon C; Vaz-Luis I; Martin AL; Everhard S; Broutin S; Rigal O; Bousrih C; Lévy C; Lerebours F; Lange M; Joly F
    Breast Cancer Res; 2024 Jun; 26(1):93. PubMed ID: 38840166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Obesity on Cognitive Functioning in Euthymic Bipolar Patients: A Cross-Sectional and Longitudinal Study.
    Mora E; Portella MJ; Martinez-Alonso M; Teres M; Forcada I; Vieta E; Mur M
    J Clin Psychiatry; 2017; 78(8):e924-e932. PubMed ID: 28994517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for the "Chemobrain in Motion - study" (CIM - study): a randomized placebo-controlled trial of the impact of a high-intensity interval endurance training on cancer related cognitive impairments in women with breast cancer receiving first-line chemotherapy.
    Oberste M; Schaffrath N; Schmidt K; Bloch W; Jäger E; Steindorf K; Hartig P; Joisten N; Zimmer P
    BMC Cancer; 2018 Nov; 18(1):1071. PubMed ID: 30400840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
    Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
    J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-reported cognitive outcomes among adolescent and young adult patients with noncentral nervous system cancers.
    Tan CJ; Mah JJJ; Goh WL; Poon E; Harunal Rashid MF; Chan A
    Psychooncology; 2020 Aug; 29(8):1355-1362. PubMed ID: 32597001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Objective-subjective disparity in cancer-related cognitive impairment: does the use of change measures help reconcile the difference?
    O'Farrell E; Smith A; Collins B
    Psychooncology; 2017 Oct; 26(10):1667-1674. PubMed ID: 27278814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and psychological predictors of cognitive function in breast cancer patients before surgery.
    Aspelund SG; Halldorsdottir T; Agustsson G; Sigurdardottir Tobin HR; Wu LM; Amidi A; Johannsdottir KR; Lutgendorf SK; Telles R; Daly HF; Sigurdardottir K; Valdimarsdottir HB; Baldursdottir B
    Support Care Cancer; 2024 Jan; 32(1):88. PubMed ID: 38185720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Acupuncture Therapy for Chemotherapy-Related Cognitive Impairment in Breast Cancer Patients.
    Tong T; Pei C; Chen J; Lv Q; Zhang F; Cheng Z
    Med Sci Monit; 2018 May; 24():2919-2927. PubMed ID: 29735975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognition, quality-of-life, and symptom clusters in breast cancer: Using Bayesian networks to elucidate complex relationships.
    Xu S; Thompson W; Ancoli-Israel S; Liu L; Palmer B; Natarajan L
    Psychooncology; 2018 Mar; 27(3):802-809. PubMed ID: 29055062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women's experiences of cancer-related cognitive impairment, its impact on daily life and care received for it following treatment for breast cancer.
    Bolton G; Isaacs A
    Psychol Health Med; 2018 Dec; 23(10):1261-1274. PubMed ID: 30048158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of cancer survivors clustered by subjective and objective cognitive function scores.
    Goto T; Saligan LN; Juneau P; Gonsalves SG; Rio CJ; Graves LY; Von Ah D
    Cancer Med; 2024 Jun; 13(12):e7255. PubMed ID: 39185749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between psychological distress, subjective cognitive complaints and objective neuropsychological functioning in brain tumor patients.
    Pranckeviciene A; Deltuva VP; Tamasauskas A; Bunevicius A
    Clin Neurol Neurosurg; 2017 Dec; 163():18-23. PubMed ID: 29035741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported chemotherapy-related cognitive impairment compared with cognitive complaints following menopause.
    Vega JN; Dumas J; Newhouse PA
    Psychooncology; 2018 Sep; 27(9):2198-2205. PubMed ID: 29904964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment Cancer-Related Cognitive Impairment in Hodgkin Lymphoma Patients.
    Juríčková V; Fayette D; Jonáš J; Fajnerová I; Kozák T; Horáček J
    Curr Oncol; 2023 Oct; 30(10):9028-9038. PubMed ID: 37887552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reported cognitive impairment in cervical cancer survivors: A cross-sectional study.
    Areklett EW; Fagereng E; Bruheim K; Andersson S; Lindemann K
    Psychooncology; 2022 Feb; 31(2):298-305. PubMed ID: 34516040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study.
    Chae JW; Chua PS; Ng T; Yeo AHL; Shwe M; Gan YX; Dorajoo S; Foo KM; Loh KW; Koo SL; Chay WY; Tan TJY; Beh SY; Lim EH; Lee GE; Dent R; Yap YS; Ng R; Ho HK; Chan A
    Breast Cancer Res Treat; 2018 Apr; 168(3):713-721. PubMed ID: 29313215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.